Biosino Bio-Technology & Science, Inc. Class H

As of June 30, 2024, Biosino Bio-Technology & Science, Inc. Class H carries a market capitalization of 91.18M, placing it among publicly traded companies globally. Its enterprise value stands at 230.79M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2024, Biosino Bio-Technology & Science, Inc. Class H has 144.71M shares outstanding.

These figures are as of June 30, 2024.

As of June 30, 2024, Biosino Bio-Technology & Science, Inc. Class H maintains a current ratio of 1.04, meaning it holds 1.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2024.

Over the twelve months ended June 30, 2024, Biosino Bio-Technology & Science, Inc. Class H recorded 661,886.14 in income tax expense.

As of the close on October 23, 2026, Biosino Bio-Technology & Science, Inc. Class H's stock has gained approximately 277.50% over the past 52 weeks. The 50-day moving average sits at 3.20, while the 200-day moving average is 3.48.

As of June 30, 2024, Biosino Bio-Technology & Science, Inc. Class H holds 37.69M in cash and equivalents against 160.23M in total debt, resulting in a net debt position of 114.15M. Total book value stands at 211.87M, with working capital of 13.65M providing operational flexibility.